Brian Lenz, EVP, CFO at ADMA BIOLOGICS, INC. (ADMA), bought 6,993 shares at $2.86 ($20K) on 2022-12-09, disclosed to the SEC on 2022-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ADMA | BUY | 2020-08-12 | $12K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $25K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $20K | — | Filing → |